Toluene-treated cell suspensions of Bacteroides fragilis were used to screen clinical isolates for the production of f3lactamase. Approximately one-third of the isolates possessed considerable cephalosporinase activity. A significant correlation was found between f3lactamase production and resistance to cephalosporin antibiotics. Several isolates were resistant to cefuroxime and cefamandole and produced enzymes capable of hydrolyzing these antibiotics. However, none of the 79 strains tested could hydrolyze the cephamycin derivative, cefoxitin. A large percentage (>90%) of the strains were susceptible to cefoxitin. Therefore, resistance to lactamase hydrolysis is a major factor for the effectiveness of cefoxitin against B. fragilis. Detailed studies of four isolates suggest that two different enzymes may be produced. Both are cephalosporinases but differ with regard to cellular distribution and substrate specificity. Cefoxitin is not a substrate for either enzyme, but it is an excellent competitive inhibitor (Ki -0.1 FM).Cephalosporins are broad-spectrum antibiotics with activity against most gram-positive and gram-negative bacteria. Among the exceptions to this general rule are members of the gram-negative species Bacteroides fragilis. Martin et al. (11) in a study of 195 clinical isolates, found that only 9% were susceptible to 25 ,g or less of cephalothin per ml. Although cephaloridine has generally proven to be more effective, Kislak (9) found only 50% of 40 isolates to be sensitive to 25 ug or less per ml. These observations have since been confirmed by others (21,22).Recently, cefoxitin (a semisynthetic cephamycin analogue) was demonstrated to be considerably more effective against B. fragilis than the cephalosporins now in use (21,22). Over 95% of the strains tested by the two groups were susceptible to 32 ,ug or less of cefoxitin per ml. Of the several hypotheses available to explain the effectiveness of cefoxitin against this group of bacteria, perhaps the most attrac-